Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Asthma Clinical Trial
Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
583
mi
from
San Antonio, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of ZN-c5 in Subjects With Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
618
mi
from
Nashville, TN
Click here to add this to my saved trials
HIV-1/HBV Co-Infection Clinical Trial
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Be Well Medical Center
838
mi
from
Berkeley, CA
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Professionals
403
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Biopharma Informatic Inc.
563
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
IMA Medical Research PC
1296
mi
from
Kew Gardens, NY
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Tandem Clinical Research
700
mi
from
Marrero, LA
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Alabama Medical Group, P.C.
735
mi
from
Mobile, AL
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Northern California Research Corp
1277
mi
from
Sacramento, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
517
mi
from
Austin, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
814
mi
from
Bexley, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
1137
mi
from
Corning, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
250
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
569
mi
from
Houston, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site 1
1321
mi
from
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
812
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Oncology and Hematology Associates
346
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
North Shore Hematology Oncology Associates PC DBA NY Cancer and Blood Specialists
1334
mi
from
East Setauket, NY
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1445
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1064
mi
from
Raleigh, NC
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease Clinical Trial
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1130
mi
from
Riverside, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
806
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
719
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
347
mi
from
Dallas, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
1225
mi
from
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
1158
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Valley Hospital North
746
mi
from
Dayton, OH
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Doctors Park
853
mi
from
East China Township, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Broadway Medical Center
633
mi
from
Fargo, ND
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford South University Medical Center
631
mi
from
Fargo, ND
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of Marlette
863
mi
from
Marlette, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Marjorie Weinberg Cancer Center at Loyola-Gottlieb
601
mi
from
Melrose Park, IL
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
1058
mi
from
Nampa, ID
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
CarolinaEast Medical Center
1165
mi
from
New Bern, NC
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Oconto Falls
702
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Center
836
mi
from
Pontiac, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
21st Century Oncology-Pontiac
836
mi
from
Pontiac, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Medical Center Saint Joseph
670
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Huron Gastroenterology PC
810
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
403
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
158
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
261
mi
from
Omaha, NE
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
1153
mi
from
Orange, CA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
1112
mi
from
Tampa, FL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery
Status: Enrolling
Updated: 12/31/1969
Slade & Baker Vision
570
mi
from
Houston, TX
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
A Study to Compare Five Different Treatment Regimens of CNTX-4975 for Participants With Chronic, Moderate-to-Severe Osteoarthritis Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
DelRicht Research
693
mi
from
New Orleans, LA
Click here to add this to my saved trials
Hematology Clinical Trial
KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Status: Enrolling, Phase II
Updated: 12/31/1969
Health Partners Institute
554
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
McLeod Center for Cancer Treatment and Research
1037
mi
from
Florence, SC
Click here to add this to my saved trials
Neurology Clinical Trial
Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Status: Enrolling, Phase
Updated: 12/31/1969
Quality Living
264
mi
from
Omaha, NE
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Sierra Clinical Research
960
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
GCP Clinical Research, LLC
1114
mi
from
Tampa, FL
Click here to add this to my saved trials
Amyloidogenic Transthyretin (ATTR) Amyloidosis Clinical Trial
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Status: Enrolling, Phase I
Updated: 12/31/1969
Centro Hospitalar do Porto
4540
mi
from
Porto,
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
1307
mi
from
Albany, NY
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
517
mi
from
Austin, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
630
mi
from
Avon, IN
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
781
mi
from
Bountiful, UT
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
820
mi
from
Canton, MI
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
1059
mi
from
Charleston, SC
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
1266
mi
from
East Brunswick, NJ
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
695
mi
from
Franklin, IN
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
1213
mi
from
Harleysville, PA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
196
mi
from
Kansas City, KS
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
622
mi
from
Kenosha, WI
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
967
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
797
mi
from
Maumee, OH
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
493
mi
from
Natchitoches, LA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
1139
mi
from
Orlando, FL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
190
mi
from
Overland Park, KS
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
609
mi
from
Skokie, IL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
664
mi
from
Tullahoma, TN
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
1134
mi
from
Vista, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
1135
mi
from
Wilmington, NC
Click here to add this to my saved trials
Obesity Clinical Trial
Circadian Misalignment and Energy Balance
Status: Enrolling
Updated: 12/31/1969
New York Obesity Nutrition Research Center
1290
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Status: Enrolling, Phase II
Updated: 12/31/1969
National Marrow Donor Program
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of SWLA, LLC
582
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Atlantic Health Specialists
931
mi
from
Galax, VA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research, San Pablo
1332
mi
from
San Pablo, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
UMASS Memorial Medical Center
1406
mi
from
Worcester, MA
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0003 404
1056
mi
from
Buffalo, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0010 702
569
mi
from
Houston, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0009 903
1080
mi
from
Ocala, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0013 962
584
mi
from
Owensboro, KY
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ps0002 212
1182
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Huntington's Disease Clinical Trial
Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas Health Science Center@Houston McGovern Medical School-
572
mi
from
Houston, TX
Click here to add this to my saved trials
Post Partum Depression Clinical Trial
A Study to Assess the Safety and Efficacy of Brexanolone in the Treatment of Adolescent Female Subjects With Postpartum Depression
Status: Enrolling, Phase III
Updated: 12/31/1969
Sage Investigational Site
844
mi
from
Chandler, AZ
Click here to add this to my saved trials
Post Partum Depression Clinical Trial
A Study to Assess the Safety and Efficacy of Brexanolone in the Treatment of Adolescent Female Subjects With Postpartum Depression
Status: Enrolling, Phase III
Updated: 12/31/1969
Sage Investigational Site
569
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
NEXT Oncology
568
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
Status: Enrolling
Updated: 12/31/1969
Virginia Tech Carilion School of Medicine and Research Institute
979
mi
from
Roanoke, VA
Click here to add this to my saved trials
Preeclampsia Postpartum Clinical Trial
Postpartum Low-Dose Aspirin and Preeclampsia
Status: Enrolling, Phase II
Updated: 12/31/1969
Columbia University Irving Medical Center
1225
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial
Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
1301
mi
from
Harrison, NY
Click here to add this to my saved trials
Pan Tumor Clinical Trial
A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
5602
mi
from
Capital Federal,
Click here to add this to my saved trials
Pan Tumor Clinical Trial
A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
397
mi
from
Tyler, TX
Click here to add this to my saved trials
Metastatic Colorectal Cancer Clinical Trial
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institite
1441
mi
from
Boston, MA
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Houston Clinical Trials, LLC
564
mi
from
Bellaire, TX
Click here to add this to my saved trials
Amblyopia Clinical Trial
Regimens of Intermittent Occlusion Therapy for Amblyopia in Children
Status: Enrolling
Updated: 12/31/1969
Salus University
1227
mi
from
Elkins Park, PA
Click here to add this to my saved trials